npj Precision Oncology, 2025 Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment Cui S., Zheng H., Xu Y. et al. Olink Target 96OncologyImmunotherapyPatient StratificationPlasma | | | | |
Arthritis & Rheumatology, 2025 Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development Rachid Zaim S., Savage A., Gillespie M. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum | | | | |
Cell Genomics, 2025 Integration of biobank-scale genetics and plasma proteomics reveals evidence for causal processes in asthma risk and heterogeneity Donoghue L., Benner C., Chang D. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Cell Reports Medicine, 2025 Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipients Hu M., Oliveira A., Fang Z. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Mediators of Inflammation, 2025 Causal Associations of Inflammatory Cytokines With Osteosarcopenia: Insights From Mendelian Randomization and Single Cell Analysis Wu Z., Yang J., Zhu Y. et al. Olink Target 96AgingPathophysiologyPlasma | | | | |
Neurological Research, 2025 Mediators of the causal associations between protein ratios and ischemic stroke: a two-step Mendelian randomization study Tan H., Chen H., Yan H. et al. Olink Explore 3072/384NeurologyPathophysiologyPlasma | | | | |
International Journal of Cancer, 2025 Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer Cooley V., Fortner R., Mukama T. et al. Olink Target 96OncologyPatient StratificationPlasma | | | | |
Nature Medicine, 2025 Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial Temba G., Pecht T., Kullaya V. et al. Olink Target 96Nutritional SciencePathophysiologyPlasma | | | | |
Journal of Proteome Research, 2025 Identification of Salivary Biomarkers in Colorectal Cancer by Integrating Olink Proteomics and Metabolomics Su H., Gu X., Zhang W. et al. Olink Target 96OncologyPatient StratificationSaliva | | | | |
Urolithiasis, 2025 Effect of the plasma metabolites, biomarkers, and inflammatory proteins on urolithiasis: insights from Mendelian randomization and mediation analysis Huang H., Wen Z., Li H. et al. Olink Target 96UrologyPathophysiologyPlasma | | | | |
Diabetes Care, 2025 Large-Scale Proteomics Improve Risk Prediction for Type 2 Diabetes Xie R., Vlaski T., Trares K. et al. Olink Target 96Olink Explore 3072/384Metabolic DiseasesPatient StratificationPlasma | | | | |
Cell Reports, 2025 Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic Molinos-Albert L., Rubio R., Martín-Pérez C. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Proceedings of the National Academy of Sciences, 2025 Nuclear Galectin-1 promotes
KRAS
-dependent activation of pancreatic cancer stellate cells Vinaixa J., Martínez-Bosch N., Gibert J. et al. Olink Target 96OncologyPathophysiologyCell Culture Supernatant | | | | |
Cell Reports Medicine, 2025 TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors Plummer R., Sodergren M., Hodgson R. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Annals of Laboratory Medicine, 2025 Pancreatic Cancer Detection and Differentiation from Chronic Pancreatitis: Potential Biomarkers Identified through a High-Throughput Multiplex Proteomic Assay and Machine Learning-Based Analysis Kim Y., Kim S., Lee S. Olink Target 96OncologyPatient StratificationSerum | | | | |
Discover Oncology, 2025 Appraising the causal role of cathepsins in genitourinary carcinoma: a two-sample mendelian randomization and prospective study based on 36,225 individuals Zhu Q., Liu D., Liu H. et al. Olink Explore 3072/384OncologyPathophysiologyPlasma | | | | |
Annals of Clinical and Translational Neurology, 2025 CSF Tau Is a Biomarker of Hippocampal Injury in Cryptogenic New‐Onset Refractory Status Epilepticus Goh Y., Jang Y., Shin S. et al. Olink Target 96Olink Target 48NeurologyPatient StratificationPlasmaCSF | | | | |
PLOS Computational Biology, 2025 Putting computational models of immunity to the test—An invited challenge to predict B.pertussis vaccination responses Shinde P., Willemsen L., Anderson M. et al. Olink Target 96Infectious DiseasesTechnical EvaluationPlasma | | | | |
PLOS Neglected Tropical Diseases, 2025 Transcriptional and cytokine signatures of Mycobacterium abscessus complex pulmonary disease during disease progression and treatment Syenina A., Tan Y., Tng D. et al. Olink Target 48Respiratory DiseasesInfectious DiseasesPatient StratificationPlasma | | | | |
Brain, Behavior, and Immunity, 2025 CCL25 in the cerebrospinal fluid is negatively correlated with fatigue in chronic pain patients Rosenström A., Ahmed A., Farinotti A. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasmaCSF | | | | |